Discontinuation report STAXYN
Report ID | 163103 |
Drug Identification Number | 02372436 |
Brand name | STAXYN |
Common or Proper name | VARDENAFIL |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | VARDENAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 4's |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-06-30 |
Actual discontinuation date | |
Remaining supply date | 2018-11-13 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-06-20 | English | Compare |
v2 | 2022-06-20 | French | Compare |
Showing 1 to 2 of 2